What did Morgan Stanley change in its LIN analyst rating on Feb 06, 2026?

Morgan Stanley maintained an **Overweight** rating on **Feb 06, 2026** and raised the price target to **$530** from **$495**, according to TheFly. The firm left the rating intact while increasing its long-term price outlook.

How does the new LIN price target compare to the current stock price?

With Linde near **$447.55**, Morgan Stanley’s **$530** target implies about **$82.45** upside or roughly **18%** from that quote. Investors should factor in volatility and time horizon before trading.

What does the Overweight rating mean for my portfolio?

An Overweight rating means the analyst expects Linde to outperform its sector. It suggests relative overweighting in diversified portfolios, not an all-in buy. Assess individual risk tolerance and valuation before changing allocations.

How does Meyka AI view LIN after this action?

Meyka AI rates **LIN with a grade of B+**. The grade reflects S&P comparison, sector performance, growth, metrics, and analyst consensus. This is informative research, not financial advice.

Analyst Ratings

Morgan Stanley Maintains Overweight on Linde plc (LIN) Feb 2026

ByDanny Kontos February 9, 2026February 9, 2026

LIN analyst rating: Morgan Stanley maintained an Overweight on Linde plc on Feb 06, 2026, and raised its price target to $530 from $495. This move keeps Morgan Stanley’s positive stance intact while signaling confidence in Linde’s industrial gases growth. Our review links the rating action to recent earnings and the stock’s near-term outlook. We note the official update time as Feb 06, 2026 at 10:52 AM and the reported short-term price change of -0.86% ($-3.87).